Literature DB >> 21990127

Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data.

Karel Fišer1, Tomáš Sieger, Angela Schumich, Brent Wood, Julie Irving, Ester Mejstříková, Michael N Dworzak.   

Abstract

Flow cytometry is a valuable tool in research and diagnostics including minimal residual disease (MRD) monitoring of hematologic malignancies. However, its gradual advancement toward increasing numbers of fluorescent parameters leads to information rich datasets, which are challenging to analyze by standard gating and do not reflect the multidimensionality of the data. We have developed a novel method to analyze complex flow cytometry data, based on hierarchical clustering analysis (HCA) but with a new underlying algorithm, using Mahalanobis distance measure. HCA is scalable to analyze complex multiparameter datasets (here demonstrated on up to 12 color flow cytometry and on a 20-parameter synthetic dataset). We have validated this method by comparison with standard gating approaches when performed independently by expert cytometrists. Acute lymphoblastic leukemia blast populations were analyzed in diagnostic and follow-up datasets (n = 123) from three centers. HCA results correlated very well (Passing-Bablok correlation coefficient = 0.992, slope = 1, intercept = -0.01) with standard gating data obtained by the I-BFM FLOW-MRD study group. To further improve the performance in follow-up samples with low MRD levels and to automate MRD detection, we combined HCA with support vector machine (SVM) learning. HCA in combination with SVM provides a novel diagnostic tool that not only allows analysis of increasingly complex flow cytometry data but also is less observer-dependent compared with classical gating and has potential for automation.
Copyright © 2011 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Year:  2011        PMID: 21990127     DOI: 10.1002/cyto.a.21148

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  13 in total

1.  Light-sheet-based 2D light scattering cytometry for label-free characterization of senescent cells.

Authors:  Meiai Lin; Xu Qiao; Qiao Liu; Changshun Shao; Xuantao Su
Journal:  Biomed Opt Express       Date:  2016-11-16       Impact factor: 3.732

Review 2.  Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy.

Authors:  Zhiyu Liu; Yang Li; Ce Shi
Journal:  Int J Hematol       Date:  2021-01-27       Impact factor: 2.490

3.  Detection of minimal residual disease in B lymphoblastic leukemia using viSNE.

Authors:  Joseph A DiGiuseppe; Michelle D Tadmor; Dana Pe'er
Journal:  Cytometry B Clin Cytom       Date:  2015-06-02       Impact factor: 3.058

Review 4.  Should minimal residual disease monitoring in acute lymphoblastic leukemia be standard of care?

Authors:  Dario Campana
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

Review 5.  Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future.

Authors:  J M Jaso; S A Wang; J L Jorgensen; P Lin
Journal:  Bone Marrow Transplant       Date:  2014-05-19       Impact factor: 5.483

6.  Endogenous light scattering as an optical signature of circulating tumor cell clusters.

Authors:  Joe Lyons; Michael Polmear; Nora D Mineva; Mathilde Romagnoli; Gail E Sonenshein; Irene Georgakoudi
Journal:  Biomed Opt Express       Date:  2016-02-25       Impact factor: 3.732

7.  Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients.

Authors:  Jedrzej Hoffmann; Evgeniya V Shmeleva; Stephen E Boag; Karel Fiser; Alan Bagnall; Santosh Murali; Ian Dimmick; Hanspeter Pircher; Carmen Martin-Ruiz; Mohaned Egred; Bernard Keavney; Thomas von Zglinicki; Rajiv Das; Stephen Todryk; Ioakim Spyridopoulos
Journal:  Circ Res       Date:  2014-11-10       Impact factor: 17.367

8.  Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium.

Authors:  Greg Finak; Marc Langweiler; Maria Jaimes; Mehrnoush Malek; Jafar Taghiyar; Yael Korin; Khadir Raddassi; Lesley Devine; Gerlinde Obermoser; Marcin L Pekalski; Nikolas Pontikos; Alain Diaz; Susanne Heck; Federica Villanova; Nadia Terrazzini; Florian Kern; Yu Qian; Rick Stanton; Kui Wang; Aaron Brandes; John Ramey; Nima Aghaeepour; Tim Mosmann; Richard H Scheuermann; Elaine Reed; Karolina Palucka; Virginia Pascual; Bonnie B Blomberg; Frank Nestle; Robert B Nussenblatt; Ryan Remy Brinkman; Raphael Gottardo; Holden Maecker; J Philip McCoy
Journal:  Sci Rep       Date:  2016-02-10       Impact factor: 4.379

9.  Measurements of treatment response in childhood acute leukemia.

Authors:  Dario Campana; Elaine Coustan-Smith
Journal:  Korean J Hematol       Date:  2012-12-24

10.  High-throughput 13-parameter immunophenotyping identifies shifts in the circulating T-cell compartment following reperfusion in patients with acute myocardial infarction.

Authors:  Jedrzej Hoffmann; Karel Fiser; Jolanta Weaver; Ian Dimmick; Monika Loeher; Hanspeter Pircher; Carmen Martin-Ruiz; Murugapathy Veerasamy; Bernard Keavney; Thomas von Zglinicki; Ioakim Spyridopoulos
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.